Piramal Pharma Limited has informed the Exchange regarding a press release dated March 20, 2025, titled "Press Release - Piramal Critical Care and BrePco announces MHRA approval for Neoatricon? in the UK".
Press Release Mar 20 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Piramal Pharma
- Piramal Pharma Limited Announces Results for Q3 and 9M FY25
- Press Release Jan 28 2025
- Press Release Jan 22 2025
- Piramal Pharma Limited Converts the Coal-Fired Steamer at its Digwal Facility to Operate on Biomass Briquettes, Advancing Decarbonization Efforts
- Press Release Oct 23 2024
Later from Piramal Pharma
- Piramal Pharma Ltd. Continues to Invest In USA; $90M in Expansions of Two US Sites
- Press Release May 14 2025
- Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan
- Piramal Pharma Limited Announces Results for Q1FY26
- Press Release Jul 28 2025
Follow Piramal Pharma into a list and get an email when it puts out news.
Follow Piramal Pharma